ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 183 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $351,000 | -64.5% | 12,600 | -59.5% | 0.03% | -83.9% |
| Q3 2016 | $989,000 | +101.8% | 31,100 | +109.9% | 0.16% | +69.5% |
| Q3 2015 | $490,000 | -21.0% | 14,815 | 0.0% | 0.10% | -42.8% |
| Q2 2015 | $620,000 | +28.4% | 14,815 | 0.0% | 0.17% | +17.7% |
| Q1 2015 | $483,000 | -89.1% | 14,815 | -91.9% | 0.14% | -58.3% |
| Q1 2014 | $4,449,000 | – | 182,871 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |